Loading ...

Error:
Message:
Pharma Partnering Meetings since 1995. Made in Europe for the World.

Delegates' Comments

"…many have attended 20 or 30 times or more…"
Dr. Norbert Rau
"…have achieved a number of successful deal outcomes…"
Paul Phull
"…four times as much for half the price…"
Anke Rau and Dr. Norbert Rau
"euroPLX is sometimes tough and intense…"
Sebastien Sanial and Malgorzata Derewianka
"…a very efficient way to meet in one-to-one meetings…"
Dr. Peter Komnick and Dr. Silke Behne
"We are Platinum Sponsors of euroPLX 49 Istanbul, because…"
Rich DiCicco
"We became a returning attendee as we've never left empty-handed…"
Kees Trommelen
"…get focused on the business...just business!"
Dragan Lutz and Mario Vlasic
"I have successfully used the euroPLX meetings for licensing-in and licensing-out…"
Dr. Satyendra Kumar
"…meet your business partners at the well organized events…"
Peter van Hoogstraten and Paul C. Borghouts
"…a highly effective and pleasant way to meet…"
Ronald Kriek and Wouter Hanegraaf
"…interact with so many companies…"
Simona Aganovic and Guy Clark
"We get value for our money…"
Vilas Nagare and Sundeep V. Bambolkar
"It’s the best partnering event…"
Jinang Parekh and Vijay Agarwal
"…the only partnering conference that covers all aspects of business development…"
Dr. Hubert Ridolphi and Dr. Gerrit Hagens
"…no better event than euroPLX to enlarge your network in the
pharmaceutical business…"
Gilbert Adatte
"...good place to expand your international network..."
Ramon Brusco
"…we wouldn’t do that if there were no results!"
Patrick Tichy
"…one of the few events which attracts a cross section of attendees from all pharmaceutical sectors…"
Daniel Jones
"…the best time and cost effective way to meet new partners."
Nuray Acar and Mutlu Topal
"There is no end to new challenges at euroPLX"
Ruud Koolen
"…a basis for excellent business."
Ana Paula Branco and José Roberto Pereira
"euroPLX is the most cost-effective and time-saving way…"
David Zubeldía
"…euroPLX is the perfect place…"
Gustavo Samojeden and Hernán Bouzada
"…good opportunity for meeting with many relevant players…"
Dietmar Jannaschk and Gemma Mogas
"…a tremendous opportunity to meet new partners…"
Marc Alvarez
"…efficient and fruitful one-to-one discussions…"
Sylvie Fondanayche
"We are not aware of any other event where you can meet so many interesting partners…"
Holger and Kai Schleenhain
"I rate euroPLX very high…"
Reynhardt Van As
"euroPLX is the best pharma meeting…"
Santiago, Mar, and Josémaria Calzada
"…very good opportunity to meet existing and new business partners…"
Agnes Olszanowski and Dr. Marian Takac
"I never leave euroPLX empty-handed."
Wendell Clayton
"…the best possible way to contact a large number of people…" Shala Fardaei and Ineke Braat
"It was in this forum that we forged some of our major alliances…" Nimit Jhaveri and Biplab Kar
"…we have made a lot of money on euroPLX deals…"
Rich DiCicco
"…an ideal opportunity to meet…"
Andreas Wagner & Michel Blanc
"…extremely time and cost efficient way to make new business contacts…"
Wolfgang Bäurle
"euroPLX is the most efficient event I know…"
Patsy Carney
"…the most efficient of the Business Development forums…"
Roland Brown
"…a tremendous opportunity to network intensely…"
Elzbieta Weston & Jacek Plucienniczak

Sponsors for euroPLX 49


Platinum Sponsor
Harvest Moon Pharma Logo


Media Sponsors

Pharmalicensing
currentPartnering
GenericsWeb
Bvents
Generics Bulletin
OTC Bulletin
Pharmatching
EUBIO
B3C newswire


Regular Registration Completed. Closed.

euroPLX 49 Istanbul

4 + 5 June 2012 in Istanbul, Turkey

Click to view registered companies

euroPLX Meetings are the place for pharma deals, attended by industry executives in charge of business development, commercial operations, marketing, and brokers or consultants with clear mandates. euroPLX delivers an average of more than 23 pre-scheduled appointments per participating company.

Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event. It is displayed on the right of this page and evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution.

In addition, attending companies may offer or look for R&D services, supporting technologies (new drug delivery; medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.

euroPLX 49 Istanbul
View location in map

Registration fee: 1,300 Euro per delegate (regular). Special conditions for early registrations, and for multiple registrations by the same company.

Limited to about 120-140 companies (one or several delegates)

Registration period until May 17, 2012 (strictly no regular registrations after this date - except for additional delegates of already registered companies. No-appointments visitors are welcome after this date.)

Main session time frame for appointments: Monday, 4 June 2012 (09:30h - 18:00) and Tuesday, 5 June 2012 (08:30 - 16:30h).

Click here for detailed programme.

Venue: Hotel Conrad Istanbul
€180/200 for single/double room
€50 Bosphorus View Supplement
€80 Executive Floor Supplement
Rates include breakfast buffet, but exclude local and national taxes (8%). The room rate is subsidised by RauCon for the period 3-6 June.


Registered Companies

The country names designate the places where the attending delegates are based, not necessarily the respective company's headquarters!

Alpha-medical d.o.o. (Croatia)
BioClin B.V. (Netherlands)
Interquim, S.A. (Spain)


Cancellations

Askot International Ltd (excluded)
Auxilium Cura Innovatio (transfer to euroPLX 50)
Farmalider S.A.
Helm Portugal, Lda.
Jamp Pharma Corp.
Kwizda Pharma GmbH
Laboratorios Lesvi
Martindale Pharma (excluded)
PharmDedict Ltd.
Pharmascience Inc. (transfer to euroPLX 50)
Stada (transfer to euroPLX 50)

Contact us

phone: +49 (6222) 9807-0
e-mail: please go to contact form

euroPLX Business Developer

Receive the euroPLX newsletter!
read more

Dynamic Partnering Focus


Hourly updated partnering interests areas of registrants
General Interest Areas
Products for (click to view)
Hospital
percent
71%
Practitioner
percent
74%
Consumer
percent
68%

Development Stage (click to view)
Preclinical
percent
10%
Phase I/II
percent
14%
Phase III
percent
35%
Approved
percent
94%

IP status (click to view)
Patented
percent
55%
Biosimilar
percent
15%
Generic
percent
87%

Product category (click to view)
Prescription
percent
90%
Over-the-Counter
percent
57%
Food supplements
percent
28%

Supporting items (click to view)
Drug delivery technology
percent
23%
Medical devices
percent
27%
Diagnostics
percent
6%

Services (click to view)
R&D services
percent
20%
Clinical research services
percent
4%
Regulatory services
percent
14%
Contract manufacture
percent
40%
API supply
percent
25%
Finished product supply
percent
73%

Therapeutic Interest Areas
Cardiovascular
percent
73%
Immunology
percent
50%
Oncology
percent
64%
CNS, Neurology
percent
74%
Gastroenterology
percent
63%
Urology
percent
67%
Female/Male health
percent
56%
Pain
percent
66%
Respiratory
percent
65%
Dermatology
percent
56%
Musculo-skeletal
percent
56%
Metabolism/Endocrinology
percent
49%
Ophthalmology
percent
47%
Other therapeutic areas
percent
52%


Copyright by RauCon 1996-2012